Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen
Herlev, Denmark18 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | Arterial Occlusive Diseases, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07037433 | |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 3 | 2026-10-01 | NCT06531824 | |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 3 | 2026-09-30 | NCT07064473 | |
| Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 3 | 2026-09-17 | NCT06858839 | |
| The Role of the Amylin Analogue Cagrilintide in Bone Metabolism | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-09-10 | NCT07010432 | |
| Changing Outpatient Diabetes Care With Remote-Patient-Monitoring: A Real World Evidence Study With Pre-Post Comparison | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Not stated | 2026-07-17 | NCT07617519 | |
| Precision Nutrition Versus Standard Dietary Care: Continuous Glucose Monitoring as a Tool for Guided Nutrition Care in Type 2 Diabetes - The PRECISE-DIET Trial. -A Pilot Study | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Not applicable | 2026-07-01 | NCT06832059 | |
| Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals | Digestive System Diseases, Nutritional and Metabolic Diseases, fatty liver disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease | Recruiting | Not stated | 2026-06-11 | NCT05890365 | |
| Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2026-04-16 | NCT05578690 | |
| Steno780G Follow-up Study | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Not yet recruiting | Not stated | 2026-03-16 | NCT07474155 | |
| Disentangling the Effect of Brain Insulin Resistance on Brain Health | Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, autoimmune disease, cognitive disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, psychiatric disorder, type 1 diabetes mellitus, type 2 diabetes mellitus | Recruiting | Not stated | 2026-02-25 | NCT07374705 | |
| My Life - I Decide: A Health Promoting School Intervention | Adolescent Health; Dietary Habits; Physical Activity; Well-Being, Psychological | Active, not recruiting | Not applicable | 2026-02-17 | NCT07411677 | |
| The Impact of Changing to a New Child- and Family-centered Outpatient Diabetes Clinic Focusing on Early Involvement of the Child With Diabetes, Training in Calmness Around Diabetes Management, Healthy Lifestyle, and Creating Peer-to-peer Networks | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Enrolling by invitation | Not applicable | 2026-01-29 | NCT07377266 | |
| Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study) | Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Nutritional and Metabolic Diseases, cognitive disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, psychiatric disorder, type 2 diabetes mellitus | Recruiting | Not applicable | 2025-11-26 | NCT07250789 | |
| Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study | Diabetes Complications, Nutritional and Metabolic Diseases, diabetes mellitus, diabetic neuropathy, endocrine system disorder, glucose metabolism disease, metabolic disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, type 2 diabetes mellitus | Recruiting | Phase 2 | 2025-05-25 | NCT06906081 | |
| The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease | Angina Pectoris, Angina, Stable, Arterial Occlusive Diseases, Body Weight, Chest Pain, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Phase 4 | 2025-05-22 | NCT06606821 | |
| Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia | Albuminuria, Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypoxia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, immune system disorder, kidney disorder, metabolic disease, proteinuria, type 1 diabetes mellitus, urinary system disorder | Not yet recruiting | Phase 2 | 2025-01-27 | NCT06147232 | |
| Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, immune system disorder, kidney disorder, kidney failure, metabolic disease, type 1 diabetes mellitus, urinary system disorder | Recruiting | Phase 3 | 2025-01-10 | NCT06082063 |